Novasep bought by management and investors

Pompey, France-based Groupe Novasep has been acquired for an enterprise value of 425.0 million euros ($552.9 million) by its management and a financial investor group composed of Gilde Buy Out, Banexi Capital Partenaires and BNP Paribas. The accord was been signed on November 29, 2006, and completed on January 9, 2007.

Groupe Novasep will continue to operate through two complementary divisions contributing to around 280.0 million euros of sales. Novasep Synthesis offers custom synthesis services utilizing niche technologies to produce elaborate molecules for the pharmaceutical industry, as well as making and marketing proprietary products, typically generics. Novasep Process is a recognized leader in the field of chromatography, with particular strength in continuous processes. It provides turn-key physical purification solutions to industrial biotech, pharmaceutical and the growing bio-pharma industries. Novasep operates mainly in Europe, with subsidiaries in the USA, China and Japan and 1,300 employees working in nine sites.